Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | Market Insights | Asia Pacific | 2020

The COVID-19 pandemic will have a significant impact on the Asia Pacific aesthetic injectable market in the short term. Once the market stabilizes, however, the market will show strong growth. This growth will be primarily attributed to the rising adoption of aesthetic procedures in the untapped Chinese and Indian markets. Increasing aesthetic consciousness, growing urban populations with high disposable incomes, and the overall cost effectiveness of these procedures over surgical options are going to be the major drivers in these markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables (including BTX and dermal fillers) in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Aesthetic Energy-Based Devices – Market Insights – United States
Aesthetic energy-based device procedure volumes will be supported by the trend toward minimally invasive and noninvasive treatments. As a result, companies are investing in developing such devices…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Aesthetic Injectables – Market Insights – Europe
The European aesthetic injectable market is on a strong growth trajectory. Product innovation and differentiated offerings from leading companies are expected to propel this expansion. The…
Report
Aesthetic Injectables – Market Insights – North America
The North American aesthetic injectable market is poised for sustained growth through 2034, driven by ongoing innovation and strong consumer demand. Leading global manufacturers continue to invest…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…